Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

160
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
160
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

274
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
274
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.6K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.6K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.1K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Fatality Rate of Patients with Acute Myocardial Infarction in 253 Chest Pain Centers - China, 2019-2020.

China CDC weekly·2022
Same author

DESSO-DB: A web database for sequence and shape motif analyses and identification.

Computational and structural biotechnology journal·2022
Same author

Immunostaining of phospho-RIPK3 in L929 cells, murine yolk sacs, ceca, and small intestines.

STAR protocols·2022
Same author

Gram-negative multidrug-resistant organisms were dominant in neurorehabilitation ward patients in a general hospital in southwest China.

Scientific reports·2022
Same author

Construction of a four-mRNA prognostic signature with its ceRNA network in CESC.

Scientific reports·2022
Same author

PhenoDEF: a corpus for annotating sentences with information of phenotype definitions in biomedical literature.

Journal of biomedical semantics·2022
Same journal

Interpretable SHAP-based machine learning framework for patient satisfaction prediction: a case study in Thammasat University Hospital.

BMC medical informatics and decision making·2026
Same journal

Automated generation of structured breast ultrasound reports using BreastViT and ChatGPT.

BMC medical informatics and decision making·2026
Same journal

Shared decision-making and medication adherence among community adults with chronic diseases: a cross-sectional study in Hubei Province, China.

BMC medical informatics and decision making·2026
Same journal

Classification of periapical radiographic findings for root canal therapy decision support using deep neural networks.

BMC medical informatics and decision making·2026
Same journal

Machine learning-based risk assessment of neonatal perinatal adverse outcomes of anemia during pregnancy: a modeling study.

BMC medical informatics and decision making·2026
Same journal

Intelligent differentiation between Parkinson's disease and essential tremor using wearable sensors and machine learning: a temporal validation study.

BMC medical informatics and decision making·2026
See all related articles

Related Experiment Video

Updated: Dec 26, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

Mining and visualizing high-order directional drug interaction effects using the FAERS database.

Xiaohui Yao1, Tiffany Tsang2, Qing Sun1

  • 1Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.

BMC Medical Informatics and Decision Making
|March 19, 2020
PubMed
Summary
This summary is machine-generated.

This study introduces an efficient data mining approach and visualization tool to identify and present complex drug-drug interactions (DDIs) involving multiple medications, improving the prediction of adverse drug events (ADEs). The findings reveal novel DDIs linked to myopathy, enhancing patient safety.

Keywords:
AprioriDirectional effectFAERSHigh-order drug interactionSunburst

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.4K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K

Related Experiment Videos

Last Updated: Dec 26, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.4K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K

Area of Science:

  • Pharmacovigilance
  • Data Mining
  • Computational Biology

Background:

  • Adverse drug events (ADEs) frequently arise from drug-drug interactions (DDIs).
  • Existing data mining methods primarily focus on pairwise DDIs, with limitations in analyzing high-order interactions computationally and visually.
  • Recent advancements explore directional relationships in high-dimensional drug combinations for ADE risk prediction, but efficiency remains a challenge for interactions involving more than three drugs.

Purpose of the Study:

  • To develop an efficient computational approach for estimating directional effects of high-order DDIs.
  • To create a novel visualization tool for organizing and presenting complex, high-order directional DDI effects.
  • To identify novel DDIs associated with myopathy using a public dataset.

Main Methods:

  • Employed frequent itemset mining to efficiently estimate directional effects of high-order DDIs.
  • Developed an interactive visualization method for presenting high-order directional DDI findings.
  • Utilized a publicly available FAERS dataset to mine DDIs associated with myopathy.

Main Results:

  • Successfully identified directional DDIs involving up to seven drugs.
  • Confirmed known myopathy-associated DDIs (e.g., fusidic acid with statins).
  • Discovered novel DDIs linked to increased myopathy risk, including combinations with zoledronate, antibiotics (ciprofloxacin, levofloxacin), and analgesics (acetaminophen, fentanyl, gabapentin, oxycodone).
  • The visualization tool allows interactive exploration of DDI networks.

Conclusions:

  • Developed an efficient data mining strategy and a scalable visualization tool for high-order DDIs.
  • The proposed method and tool can advance drug interaction research.
  • Potential to significantly impact patient healthcare by improving understanding of complex DDIs.